Ozempic and Wegovy officially moved off FDA’s drug shortage list
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
How the FDA's approval for food additives works, and why experts say a loophole allows companies to bypass it
Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...
Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...
FDA moves to rehire medical device staffers fired only days earlier
The reversal is the latest example of President Donald Trump and billionaire Elon Musk’s chaotic approach to cost-cutting, ...
FDA delays when a final rule on what foods can be labeled as ‘healthy’ goes into effect
The US Food and Drug Administration’s new standards for foods to meet before they can be labeled as “healthy” on their ...
Healio2m
FDA approves expanded label for Izervay
This is a developing news story. Please check back soon for updates. The FDA approved expanded prescribing information for ...
Yearslong shortage of popular weight-loss and diabetes drugs resolved, FDA says
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...
Pfizer Names Former FDA Drug Chief as Top Doctor
Pfizer Inc. appointed the Food and Drug Administration’s former top drug reviewer to serve as its chief medical officer.
FDA announces end to Wegovy and Ozempic drug shortages, but it could mean higher prices
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...
Cystic Fibrosis Foundation32m
More than 150 Advocates Call on Congress to Protect the NIH, FDA, and Medicaid
Volunteers shared personal stories about life with CF while urging members of Congress to protect patients and progress.
STAT3h
Patrizia Cavazzoni, former head of FDA’s drug center, joins Pfizer as chief medical officer
Patrizia Cavazzoni, formerly the top regulator of the drug division of the FDA, will join Pfizer as chief medical officer.